Tahir H., Rohrer J., Bhatia A., Wegener WA, Isenberg DAHumanized anti-CD20 monoclonal antibody in the treatment of severe resistant systemic lupus erythematosus in a patient with antibodies against rituximab . Rheumatology2005; 44: 561-562.
2.
Stein R., Qu Z., Chen S., et al. Characterization of a new humanized anti-CD20 monoclonal antibody, IMMU-106, and its use in combination with the humanized anti-CD22 antibody, epratuzumab, for the therapy of non-Hodgkin’s lymphoma. Clin Cancer Res2004; 10: 2868-2878.
3.
Mojcik AF, Klippel JHEnd-stage renal disease and systemic lupus erythematosus. Am J Med1996; 101: 100-107.
